Skip to main content
. 2020 Dec 22;60(7):3388–3397. doi: 10.1093/rheumatology/keaa793

Fig. 1.

Fig. 1

Circulating levels of anti-dsDNA, anti-histone 2 A and anti-histone 3 IgG2

Circulating levels of anti-dsDNA, anti-histone 2A and anti-histone 3 IgG2 were determined in a cohort of 91 LN patients recruited at the time of the diagnosis and were then followed for 36 months. In all cases, antibodies were of the IgG2 isotype and levels were calculated as Relative Intensity value (RU/ml) given the absence of WHO international standards. * indicates a statistical difference with T0. WHO: World Health Organisation.